Asymmetry Capital Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-52,702
| Closed | -$9.36M | – | 39 |
|
|
2021
Q2 | $9.36M | Sell |
52,702
-21,462
| -29% | -$3.81M | 6.44% | 6 |
|
|
2021
Q1 | $12.2M | Sell |
74,164
-15,725
| -17% | -$2.58M | 6.31% | 1 |
|
|
2020
Q4 | $14.8M | Buy |
89,889
+78,442
| +685% | +$12.9M | 6.76% | 3 |
|
|
2020
Q3 | $1.63M | Buy |
+11,447
| New | +$1.63M | 1.05% | 28 |
|
|
2019
Q3 | – | Sell |
-63,940
| Closed | -$9.12M | – | 32 |
|
|
2019
Q2 | $9.12M | Buy |
+63,940
| New | +$9.12M | 4.94% | 8 |
|
|
2018
Q4 | – | Sell |
-22,144
| Closed | -$3.72M | – | 27 |
|
|
2018
Q3 | $3.72M | Sell |
22,144
-7,481
| -25% | -$1.26M | 3.44% | 10 |
|
|
2018
Q2 | $5.1M | Sell |
29,625
-1,679
| -5% | -$289K | 5.02% | 5 |
|
|
2018
Q1 | $4.73M | Sell |
31,304
-13,672
| -30% | -$2.06M | 5.91% | 4 |
|
|
2017
Q4 | $6.06M | Buy |
44,976
+2,884
| +7% | +$388K | 8.22% | 3 |
|
|
2017
Q3 | $6.16M | Buy |
42,092
+10,753
| +34% | +$1.57M | 7.14% | 4 |
|
|
2017
Q2 | $4.87M | Sell |
31,339
-2,352
| -7% | -$366K | 5.78% | 4 |
|
|
2017
Q1 | $4.89M | Sell |
33,691
-8,906
| -21% | -$1.29M | 6.82% | 4 |
|
|
2016
Q4 | $4.64M | Buy |
42,597
+14,368
| +51% | +$1.57M | 8.64% | 4 |
|
|
2016
Q3 | $3.43M | Sell |
28,229
-11,311
| -29% | -$1.37M | 5.96% | 9 |
|
|
2016
Q2 | $5.59M | Buy |
+39,540
| New | +$5.59M | 10.23% | 2 |
|